All Posts: cancer research
-
Georgetown Lombardi Comprehensive Cancer Center Launches BellRinger, Local Bike Ride to End Cancer
Bike ride to raise millions to fund cancer research with inaugural October ride WASHINGTON (July 18, 2022) — Today, Georgetown Lombardi Comprehensive Cancer Center launched BellRinger, a bike ride and community movement to end cancer. BellRinger opened registration for its inaugural 25-, 50-, and 100- mile fundraising ride on Saturday, October 22, 2022 that will […]
Category: News Release
-
Survivorship Research Initiative’s New Director Hopes to Smooth a Rough Road
(June 24, 2022) — Both the American Cancer Society and the National Cancer Institute use the terms survivorship and survivor to refer to anyone with cancer, from the moment of diagnosis to the end of life. As the director of the Survivorship Research Initiative at Georgetown Lombardi Comprehensive Cancer Center, Nina Kadan-Lottick, MD, MSPH, a […]
Category: Lombardi Stories
-
Biomarkers Found That Could Be Drug Targets Against a Deadly Form of Brain Cancer
WASHINGTON (June 22, 2022) — Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing hope for a cancer that is highly lethal. Currently, the drug most often used to treat glioblastoma, temozolomide, is uniquely able to cross the blood/brain […]
Category: News Release
-
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities
Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]
Category: News Release
-
Biological Pathways Found That Drive Genomic Changes and Bone Metastasis in Ewing Sarcoma, a Rare Childhood Cancer
WASHINGTON (April 28, 2022) — In studies using mice grafted with human Ewing sarcoma tissue, researchers from Georgetown University Medical Center and colleagues have identified a biological pathway that is activated when tissue is starved of oxygen due to rapid growth of a tumor, thereby allowing cancer cells to make genetic changes so they can […]
Category: News Release
-
New Factors That Can Predict Breast Cancer Recurrence Defined
Discovery Has the Potential to Also Benefit Treatment Choices. WASHINGTON (April 22, 2022) — Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing new research avenues for preventing a new tumor from developing. […]
Category: News Release
-
Starting Mammography at Age 40 Would Reduce Disparities in Deaths for Black Women
WASHINGTON (October 18, 2021) — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths could be reduced by 57 percent compared to starting screening 10 years later, according to analyses conducted by a modeling team that is part of the Cancer Intervention and Surveillance Modeling Network (CISNET), funded […]
Category: News Release
-
Small Numbers of Cells in a Tumor Could Be Key Enablers of Cancer Metastasis
WASHINGTON (June 16, 2021) — Just a small number of cells found in tumors can enable and recruit other types of cells nearby, allowing the cancer to spread to other parts of the body, report Georgetown Lombardi Comprehensive Cancer Center scientists. Working with their research collaborators, the scientists found that “enabler cells” comprise about 20 […]
Category: News Release
-
Two Georgetown Lombardi Researchers Win Top Award in Back-to-Back Years
(March 28, 2021) — The American Society of Preventive Oncology will bestow one of its highest honors for 2020 and 2021 on two Georgetown Lombardi Comprehensive Cancer Center researchers: Jeanne Mandelblatt, MD, PhD, MPH, and Lucile Adams-Campbell, PhD. The honor, the Joseph F. Fraumeni, Jr., Distinguished Achievement Award, is given annually to a scientist with outstanding achievements […]
Category: Lombardi Stories
-
Mechanism for How Pancreatic Cancer Evades Immunotherapy Elucidated
Discovery could lead to new or improved therapeutic options. WASHINGTON (January 28, 2021) — Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor, according to a study led […]
Category: News Release